Patients, drug makers grapple with cancer clinical trials during coronavirus

Patients, drug makers grapple with cancer clinical trials during coronavirus

STAT Plus: Patients, drug makers grapple with how to continue cancer trials during the coronavirus

By ANDREW JOSEPH

KHULOUD T. AL-JAMAL, DAVID MCCARTHY & IZZAT SUFFIAN/WELLCOME

The coronavirus pandemic has thrown a wrench into plans for hundreds of clinical trials. But some investigators and sponsors are pushing ahead.

READ MORE